Luminescent, mesoporous, and bioactive europium-doped calcium silicate (MCS: Eu3+) as a drug carrier

被引:29
作者
Fan, Yong [1 ,2 ]
Huang, Shanshan [1 ]
Jiang, Jinhua [2 ]
Li, Guogang [1 ]
Yang, Piaoping [1 ]
Lian, Hongzhou [1 ]
Cheng, Ziyong [1 ]
Lin, Jun [1 ]
机构
[1] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Rare Earth Resource Utilizat, Changchun 130022, Peoples R China
[2] Jilin Univ, Coll Chem, State Key Lab Inorgan Synth & Preparat Chem, Changchun 130022, Jilin, Peoples R China
基金
中国国家自然科学基金;
关键词
Drug delivery; Luminescence; Calcium silicate; Mesoporous; Bioactive; IN-VITRO BIOACTIVITY; SIMULATED BODY-FLUID; SOL-GEL GLASSES; DELIVERY-SYSTEM; CASIO3; POWDERS; RARE-EARTH; PHOSPHATE; RELEASE; HYDROXYAPATITE; CERAMICS;
D O I
10.1016/j.jcis.2011.01.109
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Luminescent, mesoporous, and bioactive europium-doped calcium silicate (MCS: Eu) was successfully synthesized. The obtained MCS: Eu3+ was performed as a drug delivery carrier to investigate the drug storage/release properties using ibuprofen (IBU) as the model drug. The structural, morphological, textural, and optical properties were well characterized by X-ray diffraction (XRD), transmission electron microscopy (TEM), N-2 adsorption/desorption, and photoluminescence (PL) spectra, respectively. The results reveal that the MCS: Eu exhibits the typical ordered characteristics of the mesostructure. This composite shows a sustained release profile with IBU as the model drug. The IBU-loaded samples still present red luminescence of Eu3+ (D-5(0)-F-7(1.2)) under UV irradiation. The emission intensities of Eu3+ in the drug carrier system vary with the amount of released IBU, making the drug release easily tracked and monitored. The system demonstrates a great potential for drug delivery and disease therapy. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:280 / 285
页数:6
相关论文
共 49 条
  • [1] Sol-gel synthesis of a multifunctional, hierarchically porous silica/apatite composite
    Andersson, J
    Areva, S
    Spliethoff, B
    Lindén, M
    [J]. BIOMATERIALS, 2005, 26 (34) : 6827 - 6835
  • [2] Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro- and mesoporous silica matrices
    Andersson, J
    Rosenholm, J
    Areva, S
    Lindén, M
    [J]. CHEMISTRY OF MATERIALS, 2004, 16 (21) : 4160 - 4167
  • [3] Physical properties and in vitro bioactivity of hierarchical porous silica-HAP composites
    Andersson, Jenny
    Johannessen, Espen
    Areva, Sami
    Baccile, Niki
    Azais, Thierry
    Linden, Mika
    [J]. JOURNAL OF MATERIALS CHEMISTRY, 2007, 17 (05) : 463 - 468
  • [4] Wet powder processing of sol-gel derived mesoporous silica-hydroxyapatite hybrid powders
    Andersson, Jenny
    Johannessen, Espen
    Areva, Sami
    Jarn, Mikael
    Linden, Mika
    [J]. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2006, 6 (08) : 2438 - 2444
  • [5] [Anonymous], [No title captured]
  • [6] Bellamy L.J., 1975, INFRA RED SPECTRA CO, VI
  • [7] Effect of the substitution of M2O3 (M = La, Y, In, Ga, Al) for CaO on the bioactivity of 2.5CaO•2SiO2 glass
    Branda, F
    Arcobello-Varlese, F
    Costantini, A
    Luciani, G
    [J]. BIOMATERIALS, 2002, 23 (03) : 711 - 716
  • [8] Biomaterial developments for bone tissue engineering
    Burg, KJL
    Porter, S
    Kellam, JF
    [J]. BIOMATERIALS, 2000, 21 (23) : 2347 - 2359
  • [9] Induction of bioactivity of a non-bioactive glass-ceramic by a chemical treatment
    Cho, SB
    Miyaji, F
    Kokubo, T
    Nakamura, T
    [J]. BIOMATERIALS, 1997, 18 (22) : 1479 - 1485
  • [10] Boosting silica levels in wheat leaves reduces grazing by rabbits
    Cotterill, Jane V.
    Watkins, Richard W.
    Brennon, Clare B.
    Cowan, David P.
    [J]. PEST MANAGEMENT SCIENCE, 2007, 63 (03) : 247 - 253